US bioengineering company Ossium Health has treated its first leukaemia patient with cryopreserved organ donor-derived bone marrow as part of its HOPE clinical programme. Ossium’s programme ...

Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune ...

Ossium Health, Inc. announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the company a $3.46M Clinical Stage Rese ...

Ossium Health launched the HOPE Program, which further expands patient access to Ossium’s bone marrow bank. Ossium Health Launches HOPE Program to Give All Patients Hope for a Cure May 10, 2024 ...

SAN FRANCISCO, September 30, 2024--Ossium Health secures BARDA contract to advance bone marrow bank for radiological and nuclear emergencies ...

US bioengineering company Ossium Health has treated its first leukaemia patient with cryopreserved organ donor-derived bone marrow as part of its HOPE clinical programme. Ossium’s programme ...